Valuation: Giant Biogene Holding Co., Ltd.

Capitalization 33.11B 37.07B 4.75B 4.06B 3.77B 3.54B 6.57B 435B 7.03B 43.31B 17.14B 206B 17.83B 17.46B 752B P/E ratio 2025 *
15.5x
P/E ratio 2026 * 12.9x
Enterprise value 27.13B 30.37B 3.9B 3.33B 3.09B 2.9B 5.38B 357B 5.76B 35.48B 14.04B 169B 14.61B 14.31B 616B EV / Sales 2025 *
4.53x
EV / Sales 2026 * 3.6x
Free-Float
42.68%
Yield 2025 *
3.58%
Yield 2026 * 3.8%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.30%
1 week-2.24%
Current month+4.99%
1 month-1.52%
3 months-14.49%
6 months-42.25%
Current year+4.99%
More quotes
1 week 34.46
Extreme 34.46
38
1 month 32.88
Extreme 32.88
38
Current year 32.88
Extreme 32.88
38
1 year 32.88
Extreme 32.88
87.1
3 years 28.4
Extreme 28.4
87.1
5 years 24.3
Extreme 24.3
87.1
10 years 24.3
Extreme 24.3
87.1
More quotes
Manager TitleAgeSince
Chief Executive Officer 59 20/04/2022
Director of Finance/CFO 39 20/04/2022
Corporate Secretary 30 30/09/2018
Director TitleAgeSince
Chairman 59 20/04/2022
Director/Board Member 55 29/11/2021
Director/Board Member 67 05/10/2022
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.30%-2.24%-35.06%-9.25% 4.82B
-0.74%-0.28%-9.76%+3.47% 343B
+0.21%-0.96%-7.84%+3.60% 142B
-0.48%+0.14%-4.03%+12.15% 68.87B
-0.47%-0.90%+0.97%-7.09% 67.56B
+2.90%+0.65%+49.29%-57.13% 41.25B
-1.39%+1.37%-16.56% - 33.7B
+1.40%+0.08%-20.96%-11.73% 24.94B
+0.15%+0.89%-10.25%-3.62% 20.3B
-0.96%-1.36%+4.79%+31.11% 13.88B
Average +0.02%+0.85%-4.94%-4.28% 76.12B
Weighted average by Cap. -0.21%+1.31%-5.31%-0.38%
See all sector performances

Financials

2025 *2026 *
Net sales 5.98B 6.7B 859M 735M 682M 640M 1.19B 78.72B 1.27B 7.83B 3.1B 37.2B 3.22B 3.16B 136B 7.27B 8.14B 1.04B 893M 829M 777M 1.44B 95.68B 1.54B 9.51B 3.76B 45.22B 3.92B 3.84B 165B
Net income 2.14B 2.4B 307M 263M 244M 229M 424M 28.15B 454M 2.8B 1.11B 13.3B 1.15B 1.13B 48.59B 2.56B 2.87B 368M 314M 292M 274M 508M 33.68B 544M 3.35B 1.33B 15.92B 1.38B 1.35B 58.14B
Net Debt -5.98B -6.7B -859M -734M -682M -639M -1.19B -78.67B -1.27B -7.82B -3.1B -37.18B -3.22B -3.16B -136B -6.9B -7.72B -990M -847M -786M -737M -1.37B -90.73B -1.46B -9.02B -3.57B -42.88B -3.71B -3.64B -157B
More financial data * Estimated data
Logo Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive material-based beauty and health products through its subsidiaries. The Company's main products include functional skincare products and medical dressings, and they are produced with recombinant collagen as the key bioactive ingredient. The Company also develops and manufactures rare ginsenosides technology-based functional foods. The Company mainly conducts its businesses within the domestic market.
Employees
2,162
More about the company
Date Price Change Volume
21/01/26 34.94 $ -1.30% 4,744,294
20/01/26 35.40 $ +1.43% 5,343,850
19/01/26 34.90 $ -2.57% 5,896,450
16/01/26 35.82 $ -0.61% 11,090,850
15/01/26 36.04 $ +2.33% 5,901,974

Delayed Quote Hong Kong S.E., January 21, 2026 at 08:08 am

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
34.94HKD
Average target price
53.42HKD
Spread / Average Target
+52.88%
Consensus

Quarterly revenue - Rate of surprise